Global Alliance for Chronic Diseases welcomes Brazil as new member

Brazil’s São Paulo Research Foundation, FAPESP, has joined the Global Alliance for Chronic Diseases. This new collaboration with one of Latin America’s key research funders will further strengthen the GACD research network in the region.

“Having Brazil join our expanding network of researchers and research programmes in the Americas will be an invaluable contribution to the GACD. By joining the alliance, FAPESP are becoming part of a unique global network of funders that jointly support research and provide evidence to influence policy and practice in the areas of non-communicable diseases worldwide,” says Dr Alain Beaudet, Chair of the GACD.

With three active research programmes on hypertension, diabetes and lung diseases underway and a further call on mental health due to launch during the course of 2016, Brazil joins the alliance at an interesting time of expansion.

Carlos Henrique de Brito Cruz, Scientific Director, FAPESP: “We are excited by this opportunity to collaborate with key international funders. The GACD will provide a distinctive platform for fostering collaborative research to facilitate scientific collaboration between researchers in São Paulo, Brazil with a unique cohort of international non-communicable disease researchers.”

Background

FAPESP is a public foundation, funded by the taxpayer in the State of São Paulo, with the mission to support research projects in higher education and research institutions, in all fields of knowledge.

The Global Alliance for Chronic Diseases (GACD) is a collection of the world’s largest public health research funding agencies. We fund joint programmes into lifestyle related or chronic diseases (cardiovascular diseases, diabetes, certain cancers, lung diseases and mental disorders).

The alliance coordinates and supports research activities that address the prevention and treatment of chronic non-communicable diseases, on a global scale. These conditions account for 60 percent of deaths globally. Our multi-country, multi-disciplinary research focuses in particular on the needs of low- and middle-income countries, where 80% of deaths from chronic diseases occur. We also focus on research with vulnerable populations of more developed countries.

The GACD is the first collaboration of major research funding agencies to specifically address chronic non-communicable diseases. Together, the members of the alliance represent over 80% of public health research funding worldwide. Members of the alliance are:

  • Australia’s National Health and Medical Research Council
  • Canadian Institutes of Health Research
  • Chinese Academy of Medical Sciences
  • The U.K.’s Medical Research Council
  • The U.S.’s National Institutes of Health
  • Indian Council of Medical Research
  • South African Medical Research Council
  • European Commission’s Health Directorate in the Research & Innovation DG
  • Mexico’s National Institute of Medical Sciences and Nutrition Salvador Zubirán
  • Thailand’s Health Systems Research Institute
  • Argentina’s Ministry of Science, Technology and Productive Innovation
  • The Japanese Agency for Medical Research and Development
  • Brazil’s São Paulo Research Foundation – FAPESP

Further information

For press contacts, please get in touch with us at gacd@ucl.ac.uk

FAPESP is a public foundation, funded by the taxpayer in the State of São Paulo, with the mission to support research projects in higher education and research institutions, in all fields of knowledge.

Share this blog post